Chugai originated products are designed to address unmet medical needs with its proprietary technology.
Main Antibody Engineering Technology
|Technology||Feature||Product/Development Applied with Technologies|
|Recycling Antibody®||Binds to the target antigen multiple times and therefore prolong the duration of the antibody‘s efficacy||Enspryng, SKY59 (crovalimab), AMY109|
|Sweeping Antibody®||Eliminates the disease-causing (soluble) antigen from plasma||GYM329|
|Bispecific Antibody Manufacturing Technology (ART-Ig®, FAST-Ig™)||Enables commercial production of bispecific antibodies, which is expected to lead to the generation of drugs with a new mode of action that enhances efficacy by simultaneously binding with two types of antigen or provides new pharmacology by bridging two antigens.||Hemlibra, NXT007|
|T cell Redirecting AntiBody (TRAB®)||Directs T cells to cancer cells and activates T cells, specifically attacking and killing neighboring cancer cells.||ERY974|
|Switch Antibody™||Binds to the antigen only in the presence of tumor specific small molecule metabolite (switch molecule).||STA551|